SCHEMBL15324899

SCHEMBL15324899

CS(=O)(=O)c1ccc(N)cc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.62
CASP1 P29466 3/20 0.48
TSHR P16473 2/20 0.48
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 3/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 2/20 0.44
ESR2 Q92731 1/20 0.44
PTPN1 P18031 1/20 0.44
PDE10A Q9Y233 1/20 0.43
PDK2 Q15119 1/20 0.43
ALOX15 P16050 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
NSD2 O96028 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7051361 0.83 L3MBTL1 (0.57) L3MBTL1CASP1TSHRKDM4EALDH1A1
SCHEMBL712906 0.83 CYP3A4 (0.47) L3MBTL1CASP1TSHRKDM4EALDH1A1
SCHEMBL10034886 0.83 KDM4E (0.47) L3MBTL1CASP1TSHRKDM4EALDH1A1
SCHEMBL158793 0.81 NT5E (0.53) L3MBTL1CASP1TSHRKDM4EALDH1A1
Sulfuric Acid SCHEMBL6251886 0.80 L3MBTL1 (0.53) L3MBTL1CASP1TSHRKDM4EALDH1A1
SCHEMBL13212960 0.79 CASP1 (0.44) L3MBTL1CASP1TSHRKDM4EALDH1A1
SCHEMBL1413200 0.78 L3MBTL1 (0.67) L3MBTL1CASP1TSHRALDH1A1CYP3A4
SCHEMBL9336129 0.78 L3MBTL1 (0.41) L3MBTL1ALDH1A1PDK2
SCHEMBL29379850 0.78 L3MBTL1 (0.67) L3MBTL1CASP1TSHRALDH1A1CYP3A4
SCHEMBL9336134 0.78 ENPP2 (0.48) L3MBTL1TSHRALDH1A1GAAPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242903-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISEASES ONCO3R THERAPEUTICS BV (BE) 2025-11-27 WO disclosed
WO-2016187667-A1 FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS NOVOGEN LIMITED (AU) 2016-12-01 WO disclosed
WO-2013153677-A1 COSMETIC COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2013-10-17 WO disclosed